Ask Sterling

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving the EV sector growth?

Companies Sectors Compare Ask Sterling

Favorites Commodities

Vertex Pharmaceuticals (VRTX) - Compare | Sterling

Revenue Flow

Chart: Revenue Flow for Vertex Pharmaceuticals. Q2 2026, values in USD. Revenue 37%, Gross Profit 32%, Operating Income 14%, Net Income 12%, Cost of Revenue 5%.

Balance Sheet

Chart: Balance Sheet for Vertex Pharmaceuticals. Values in currency. In Q2 2026: Total Assets 27.423, Total Liabilities 7.175, Total Equity 20.248.

Q3 2016-Q2 2026

Cash Flow

Chart: Cash Flow for Vertex Pharmaceuticals. Values in currency. In Q2 2026: Operating Cash Flow 1.125, Free Cash Flow 1.013, Capital Expenditures 0.112.

Q3 2016-Q2 2026

Revenue Breakdown

Chart: Revenue Breakdown for Vertex Pharmaceuticals. Values in USD billions. In Q2 2026: Revenue 3.334, Gross Profit 2.845, Operating Income 1.247.

Revenue Flow

Chart: Revenue Flow for Vertex Pharmaceuticals. Q2 2026, values in USD. Revenue 37%, Gross Profit 32%, Operating Income 14%, Net Income 12%, Cost of Revenue 5%.

Balance Sheet

Chart: Balance Sheet for Vertex Pharmaceuticals. Values in currency. In Q2 2026: Total Assets 27.423, Total Liabilities 7.175, Total Equity 20.248.

Q3 2016-Q2 2026

Cash Flow

Chart: Cash Flow for Vertex Pharmaceuticals. Values in currency. In Q2 2026: Operating Cash Flow 1.125, Free Cash Flow 1.013, Capital Expenditures 0.112.

Q3 2016-Q2 2026

Revenue Breakdown

Chart: Revenue Breakdown for Vertex Pharmaceuticals. Values in USD billions. In Q2 2026: Revenue 3.334, Gross Profit 2.845, Operating Income 1.247.